Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26.8Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-2.9
Enterprise Value $M5.0EPS (TTM) $-0.4Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.1Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio10.3Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio10.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-58.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-64.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M46.1ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PTIE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PTIECharles Brandes 2016-09-30 Reduce$1 - $2.86
($2.37)
$ 0.58-76%Reduce -32.45%53,200
PTIEFirst Eagle Investment 2016-06-30 Add0.01%$1.99 - $2.55
($2.27)
$ 0.58-74%Add 16.15%6,602,658
PTIECharles Brandes 2016-06-30 Add$1.99 - $2.55
($2.27)
$ 0.58-74%Add 108.80%78,758
PTIECharles Brandes 2016-03-31 Add$1.6 - $2.23
($1.84)
$ 0.58-68%Add 107.92%37,719
PTIECharles Brandes 2015-12-31 Reduce$1.75 - $2
($1.89)
$ 0.58-69%Reduce -4.20%18,141
PTIECharles Brandes 2015-09-30 Buy $1.69 - $1.99
($1.8)
$ 0.58-68%New holding18,937
PTIEGeorge Soros 2015-09-30 Sold Out $1.69 - $1.99
($1.8)
$ 0.58-68%Sold Out0
PTIEGeorge Soros 2015-06-30 Buy $1.65 - $2.62
($1.96)
$ 0.58-70%New holding21,700
PTIEMario Gabelli 2015-06-30 Reduce$1.65 - $2.62
($1.96)
$ 0.58-70%Reduce -7.14%65,000
PTIEMario Gabelli 2015-03-31 Reduce$1.66 - $2.12
($1.93)
$ 0.58-70%Reduce -17.65%70,000
PTIEMario Gabelli 2014-09-30 Reduce$3.6 - $5.72
($4.32)
$ 0.58-87%Reduce -33.33%100,000
PTIEFirst Eagle Investment 2014-06-30 Add0.01%$4.58 - $6.06
($5.28)
$ 0.58-89%Add 22.14%4,474,735
PTIEGeorge Soros 2014-06-30 Sold Out -0.01%$4.58 - $6.06
($5.28)
$ 0.58-89%Sold Out0
PTIEGeorge Soros 2014-03-31 Buy 0.01%$3.92 - $5.71
($5.03)
$ 0.58-88%New holding103,700
PTIEFirst Eagle Investment 2014-03-31 Add0.01%$3.92 - $5.71
($5.03)
$ 0.58-88%Add 25.15%3,663,750
PTIEFirst Eagle Investment 2013-12-31 Add0.01%$2.61 - $4.73
($3.79)
$ 0.58-85%Add 20.37%2,927,386
PTIEMario Gabelli 2013-12-31 Reduce$2.61 - $4.73
($3.79)
$ 0.58-85%Reduce -24.00%190,000
PTIEFirst Eagle Investment 2013-09-30 Add$2.21 - $3.11
($2.5)
$ 0.58-77%Add 30.60%2,431,935
PTIEFirst Eagle Investment 2013-06-30 Add0.01%$2.21 - $5.41
($3.02)
$ 0.58-81%Add 171.01%1,862,099
PTIEFirst Eagle Investment 2013-03-31 Add$2.47 - $3.74
($3.01)
$ 0.58-81%Add 30.53%687,099
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PTIE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PTIE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROBERTSON SANFORDDirector 2013-11-06Buy50,000$3.73-84.45view
FRIEDMANN NADAVCOO 2011-10-18Sell25,000$4.44-86.94view
FRIEDMANN NADAVCOO 2011-10-04Sell25,000$4.81-87.94view
Sabretooth Master Fund, L.P.10% Owner 2011-10-04Sell382,000$4.59-87.36view
FRIEDMANN NADAVCOO 2011-09-15Sell25,000$4.89-88.14view
Sabretooth Master Fund, L.P.10% Owner 2011-08-08Sell44,417$4.2-86.19view
BARBIER REMICEO, Chairman of the Board, 10% Owner 2011-08-08Buy5,000$4.22-86.26view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-10-04Sell50,000$6.2-90.65view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-07Sell28,597$5.69-89.81view
BARBIER REMICEO & Chairman of the Board, 10% Owner 2010-09-02Sell21,403$5.81-90.02view

Quarterly/Annual Reports about PTIE:

News about PTIE:

Articles On GuruFocus.com
Wednesday Pre-Market Insights: GEVO, WPZ, HDP, PTIE May 13 2015 
Eveillard's First Eagle Increases 2 Positions Sep 11 2014 
Morning Coffee: Real-Time Picks May 14 2014 
Pain Therapeutics Reports Operating Results (10-K) Feb 03 2011 
Pain Therapeutics Reports Operating Results (10-Q) Oct 29 2010 
Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 50,000 Shares Oct 04 2010 
Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 28,597 Shares Sep 08 2010 
Pain Therapeutics (ptie) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 21,403 Shares Sep 02 2010 
Pain Therapeutics (PTIE) CEO & Chairman of the Board, 10% Owner Remi Barbier sells 22,391 Shares Aug 04 2010 
Pain Therapeutics Reports Operating Results (10-Q) Jul 29 2010 

More From Other Websites
PAIN THERAPEUTICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Nov 18 2016
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain... Nov 11 2016
Durect (DRRX) Exited Third Quarter with Strong Balance Sheet Nov 01 2016
PAIN THERAPEUTICS INC Financials Oct 29 2016
PAIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report Oct 26 2016
Pain Therapeutics reports 3Q loss Oct 20 2016
Pain Therapeutics reports 3Q loss Oct 20 2016
Pain Therapeutics Reports Q3 2016 Financial Results Oct 20 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition Oct 20 2016
Pain Therapeutics Reports Q3 2016 Financial Results Oct 20 2016
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain... Oct 11 2016
Pomerantz Law Firm Announces Summary Notice of Pendency and Proposed Settlement of Pain... Oct 01 2016
Pain Therapeutics (PTIE) Enters Oversold Territory Sep 29 2016
Pain Therapeutics (PTIE) Down on CRL for Chronic Pain Drug Sep 28 2016
Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection Sep 26 2016
5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy Sep 26 2016
GW Pharmaceuticals (GWPH), Sally Beauty Holdings Inc. (SBH) & More: Why These Stocks Are Making... Sep 26 2016
For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million Sep 26 2016
Is Pain Therapeutics an Incredible Momentum Stock? 3 Reasons Why PTIE Will Be Tough to Beat Sep 26 2016
Get ready. One of tech’s biggest darlings is in for a bumpy ride Sep 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)